Vidya Vasu-Devan

Vidya leads GHIC’s investment team and chairs its investment committee. A pioneer of investing in global health, GHIC has been supporting high-impact biomedical innovations for over a decade.  Previously, Vidya was the Chief Strategy Officer of a venture-backed newco focused on development of best-in-class vaccines. Prior to that, she spent over a decade at the Gates Foundation where she led the $2.5bn Strategic Investment Fund (“SIF”) and chaired the SIF Investment Committee.  In this capacity, Vidya worked across sectors and geographies to source, structure, and manage venture capital, debt, and guarantee investments and led the foundation’s investment effort in vaccines and biologics. Previously, Vidya was an investment professional in the public markets proprietary hedge fund of Goldman Sachs (GSPS) where she led the healthcare portfolio and invested in financial institutions. Vidya started her career in investment banking at Goldman Sachs, advising and executing on innovative structured finance transactions for financial institution clients. Vidya received an MBA and a Public Management and Social Innovation certificate from the Stanford Graduate School of Business. She also holds a BA in Astrophysics with concentrations in Mathematics and Economics from Columbia University.